Table 4.
TNM Stage | Number | Patients | MOS (months) | %survivors | ||
---|---|---|---|---|---|---|
6th TNM edition | I | 59 | 41 survivors | 35.5 | 80.4 | |
10 non-survivors | 23.1 | |||||
7 postop deaths | - | |||||
1 lost to follow-up | - | |||||
II | 6 | 3 survivors | 25.7 | 60 | ||
2 non-survivors | 14 | |||||
1 postop deaths | - | |||||
III | 7 | 1 survivor | 16 | 20 | ||
4 non-survivors | 21 | |||||
1 postop death | - | |||||
1 lost to follow-up | - | |||||
IV | 1 | 1 survivor | 30 | 100 | ||
7th TNM edition | IA | 14 | 12 survivors | 34 | 85.7 | 83.3 |
2 non-survivors | 27.5 | |||||
IB | 25 | 18 survivors | 34.2 | 81.8 | ||
4 non-survivors | 19.8 | |||||
2 postop deaths | - | |||||
1 lost to follow-up | - | |||||
IIA | 14 | 7 survivors | 42.9 | 70 | 68.2 | |
3 non-survivors | 16.3 | |||||
4 postop deaths | - | |||||
IIB | 14 | 8 survivors | 30 | 66.7 | ||
4 non-survivors | 24.3 | |||||
2 postop deaths | - | |||||
IIIA | 6 | 1 survivors | 16 | 25 | ||
3 non-survivors | 10.5 | |||||
1 postop death | - | |||||
1 lost to follow-up | - |
MOS = median overall survival; Postop death = death<1 month post-surgery; TNM = Tumor, Node and Metastasis classification.